List of Studies ( Metabolite:TG 66:11)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004095 | AN006788 | Hep3B PNPLA3 wild type and PNPLA3(I148M) lipidomics | Cultured cells | Human | Cancer | Amgen | LC-MS |
| ST003717 | AN006098 | Lipidomics analysis of mouse pancreatic cancer cells cultured RPMI, TIFM, or TIFM + arginine under lipid deprivation | Cultured cells | Mouse | Cancer | University of Chicago | LC-MS |
| ST003715 | AN006096 | Lipidomics analysis of mouse PDAC cell lines treated with tung oil | Cultured cells | Mouse | Cancer | University of Chicago | LC-MS |
| ST003714 | AN006095 | Lipidomics analysis of mouse PDAC cell lines treated with alpha-eleostearic acid | Cultured cells | Mouse | Cancer | University of Chicago | LC-MS |
| ST003090 | AN005054 | Analysis of lipid profiles of N2A-Pz1-KO cells expressing tdTOMATO-vector (mock), TMEM120A, or TMEM120B | Cultured cells | Mouse | Rutgers University | LC-MS | |
| ST002843 | AN004653 | Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Tamoxifen) | Liver | Mouse | Cancer | Rutgers University | LC-MS |
| ST002842 | AN004651 | Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Fenofibrate) | Liver | Mouse | Cancer | Rutgers University | LC-MS |
| ST002729 | AN004426 | Improved Endurance Capacity of Diabetic Mice during SGLT2 Inhibition: Potential Role of AICARP, an Endogenous AMPK Activator. | Muscle | Mouse | Diabetes | Medical Institute of Bioregulation, Kyushu University | LC-MS |
| ST000148 | AN000235 | A549 13C-labeled Cell Study | Epithelial cells | Human | Cancer | University of Kentucky | LC-MS |
| ST000110 | AN000183 | SIRM Analysis of human P493 cells under hypoxia in [U-13C/15N] labeled Glutamine medium (Both positive and ion mode FTMS) | B-cells | Human | University of Kentucky | GC-MS/LC-MS |
